-
)
Vaccinex has developed technologies to enable antibody discovery vs complex antigens such as GPCRs using both in vitro and in vivo antibody discovery platforms. Our Activmab fusion protein technology ... -
)
Ablexis and AlivaMab Biologics (AMB) together offer exceptional, integrated capabilities in efficient, successful biologics drug discovery. Our platforms include a suite of transgenic mice, “AlivaMab® ... -
)
Antiverse is a leading Generative AI TechBio company specializing in therapeutic antibody design for difficult targets, such as GPCRs, ion channels and other transmembrane proteins. Starting from only ... -
)
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, d ... -
)
Headquartered in San Jose, California, Single Cell Technology is today a leading antibody discovery service provider with a pioneering platform that can accelerate the process and capture all availabl ... -
)
It’s really simple. We enable our scientific partners in the discovery and optimization of novel antibody drugs. We are laser-focused on getting what our partners need for the next stage. That’s our c ... -
)
We enable biological engineering at a genome-scale We provide our partners with groundbreaking synthetic DNA and cell engineering services to investigate novel therapeutics, develop more sustainable p ... -
)
ImmunXperts a Q2 Solutions Company, your partner for what’s next in assay and biomarker development, advanced laboratory testing, and translational immunology. ImmunXperts brings an unrivaled ability ... -
)
Biologics discovery is a journey with unique challenges at every turn. We have developed a suite of tools targeting key areas, including antigen design, hit generation, optimization, and developabilit ... -
)
IPA (ImmunoPrecise Antibodies NASDAQ: IPA ) is a biotherapeutic research company that brings industry leading antibody discovery services and complex artificial intelligence technologies together — to ...
Partners - Antibody Therapeutics Xchange - San Francisco 2024
